MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,476,984 | -31.1% | 7,747,891 | -26.9% | 0.11% | -28.9% |
| Q4 2022 | $7,954,142 | -12.9% | 10,605,522 | 0.0% | 0.15% | -10.6% |
| Q3 2022 | $9,132,000 | -16.0% | 10,605,522 | +9.2% | 0.17% | -13.7% |
| Q2 2022 | $10,877,000 | -43.7% | 9,711,422 | -43.8% | 0.20% | -37.1% |
| Q1 2022 | $19,336,000 | -30.0% | 17,264,764 | 0.0% | 0.31% | -11.8% |
| Q4 2021 | $27,624,000 | -33.9% | 17,264,764 | 0.0% | 0.36% | -22.7% |
| Q3 2021 | $41,781,000 | -23.7% | 17,264,764 | 0.0% | 0.46% | -17.1% |
| Q2 2021 | $54,730,000 | -5.9% | 17,264,764 | +0.0% | 0.55% | +1.8% |
| Q1 2021 | $58,183,000 | +17.6% | 17,264,763 | +25.0% | 0.54% | +25.6% |
| Q4 2020 | $49,463,000 | – | 13,816,488 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 3,215,001 | $4,147,351 | 2.35% |
| Soleus Capital Management, L.P. | 9,677,419 | $12,483,871 | 1.15% |
| 683 Capital Management, LLC | 6,000,000 | $7,740,000 | 0.60% |
| Rubric Capital Management LP | 11,616,120 | $14,984,795 | 0.56% |
| MANGROVE PARTNERS IM, LLC | 5,531,547 | $7,135,696 | 0.54% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $9,500,125 | 0.51% |
| DAFNA Capital Management LLC | 962,513 | $1,241,642 | 0.39% |
| Clearline Capital LP | 3,102,723 | $4,002,512 | 0.34% |
| Rock Springs Capital Management LP | 7,676,481 | $9,902,660 | 0.26% |
| Monaco Asset Management SAM | 595,729 | $768,490 | 0.23% |